Right Decisions
Back
Acute Oncology Guidelines
Suspected thromboses - antithrombotic guidelines

Please update your RDS mobile app to version 4.7.1

We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. When you install the update, you will see that each toolkit has a small QR code icon the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.

You may need to actively install the update to install RDS app version 4.7.1 to see this improvement. Installing this update is also strongly recommended to get the full benefits of the new contingency arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits.

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. To install latest updates:

On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Please get in touch with ann.wales3@nhs.scot with any questions.

Suspected thromboses - antithrombotic guidelines

Acute Oncology Guidelines

Date	Version updated	Amendment	New version	Written by	Approved by
22/11/21	1.0	Changed recommended DOAC from edoxaban to apixaban	2.0	A Christie	CTAC
01/12/21	2.0	Correction to dalteparin dising on p6	2.1	H Dalrymple	CTAC Chair

This guideline covers suspected thromboses may be leg, chest, arm, PICC-line associated.

This guideline intends to provide general advice on anti-thrombotic therapy for adult patients living with active cancer or receiving anti-cancer therapy only. It is intended to be used alongside the detailed LUHD Antithrombotic Guidelines (Adults) which can be accessed via the link on the intranet home page under ‘applications and links’.

Treatment summary

Anti-thrombotic therapies

Thromboprophylaxis for oncology patients

Therapeutic anticoagulation for oncology patients

Prescribing apixaban

Prescribing dalteparin

Special circumstances

Appendix 1: NHS Lothian approved DOACs - pharmacological information

Appendix 2: Potential drug interactions of apixaban

Appendix 3: Bridging of patients on direct oral anticoagulants (DOACs) before surgery or invasive procedures

References